GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curasight AS (XSAT:CURAS) » Definitions » EV-to-EBITDA

Curasight AS (XSAT:CURAS) EV-to-EBITDA : -5.78 (As of Sep. 21, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Curasight AS EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Curasight AS's enterprise value is kr208.78 Mil. Curasight AS's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was kr-36.13 Mil. Therefore, Curasight AS's EV-to-EBITDA for today is -5.78.

The historical rank and industry rank for Curasight AS's EV-to-EBITDA or its related term are showing as below:

XSAT:CURAS' s EV-to-EBITDA Range Over the Past 10 Years
Min: -88.64   Med: 0   Max: 0
Current: -5.77

XSAT:CURAS's EV-to-EBITDA is ranked worse than
100% of 461 companies
in the Biotechnology industry
Industry Median: 8.5 vs XSAT:CURAS: -5.77

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-09-21), Curasight AS's stock price is kr10.50. Curasight AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was kr-1.600. Therefore, Curasight AS's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Curasight AS EV-to-EBITDA Historical Data

The historical data trend for Curasight AS's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curasight AS EV-to-EBITDA Chart

Curasight AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial - - -46.34 -10.26 -10.37

Curasight AS Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.46 -10.70 -10.37 -5.72 -6.65

Competitive Comparison of Curasight AS's EV-to-EBITDA

For the Biotechnology subindustry, Curasight AS's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curasight AS's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Curasight AS's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Curasight AS's EV-to-EBITDA falls into.



Curasight AS EV-to-EBITDA Calculation

Curasight AS's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=208.781/-36.13
=-5.78

Curasight AS's current Enterprise Value is kr208.78 Mil.
Curasight AS's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-36.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curasight AS  (XSAT:CURAS) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Curasight AS's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=10.50/-1.600
=At Loss

Curasight AS's share price for today is kr10.50.
Curasight AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1.600.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Curasight AS EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Curasight AS's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Curasight AS Business Description

Traded in Other Exchanges
N/A
Address
Ole Maaloes Vej 3, Kobenhavn N, Kobenhavn, DNK, DK-2200
Curasight AS is a biotech company focused on addressing the need for improved diagnosis and treatment of several cancer indications. The company is focused on exploiting Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor.

Curasight AS Headlines

No Headlines